NCT02541370View on ClinicalTrials.gov

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Liver CancerPancreatic CancerBrain TumorBreast CancerOvarian TumorColorectal CancerAcute Myeloid and Lymphoid Leukemias
Interventions
BIOLOGICAL

anti-CD133-CAR vector-transduced T cells

genetically engineered lymphocyte therapy

Trial Locations (1)

100853

Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT02541370 - Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | Biotech Hunter | Biotech Hunter